These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15003372)

  • 21. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.
    Donohoe G; Morris DW; Clarke S; McGhee KA; Schwaiger S; Nangle JM; Garavan H; Robertson IH; Gill M; Corvin A
    Neuropsychologia; 2007 Jan; 45(2):454-8. PubMed ID: 16930638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pupillary assessment and computational modeling of the Stroop task in depression.
    Siegle GJ; Steinhauer SR; Thase ME
    Int J Psychophysiol; 2004 Mar; 52(1):63-76. PubMed ID: 15003373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of attention deficit, rapid eye movement latency and slow wave sleep in schizophrenia patients.
    Chang YS; Hsu CY; Tang SH; Lin CY; Chen MC
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):176-9. PubMed ID: 19335387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rorschach response process in schizophrenia].
    Harada N
    Seishin Shinkeigaku Zasshi; 1996; 98(6):378-412. PubMed ID: 8810861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of attention in schizophrenia.
    Birkett P; Brindley A; Norman P; Harrison G; Baddeley A
    J Psychiatr Res; 2006 Oct; 40(7):579-88. PubMed ID: 16359710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative cognitive profiles of obsessive-compulsive disorder and schizophrenia.
    Martin V; Huber M; Rief W; Exner C
    Arch Clin Neuropsychol; 2008 Sep; 23(5):487-500. PubMed ID: 18508232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of divergent thinking to community functioning in schizophrenia.
    Nemoto T; Kashima H; Mizuno M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):517-24. PubMed ID: 17218048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced novelty-P3 associated with increased behavioral distractibility in schizophrenia.
    Cortiñas M; Corral MJ; Garrido G; Garolera M; Pajares M; Escera C
    Biol Psychol; 2008 Jul; 78(3):253-60. PubMed ID: 18450358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into feature and conjunction search: II. Evidence from Alzheimer's disease.
    Porter G; Leonards U; Wilcock G; Haworth J; Troscianko T; Tales A
    Cortex; 2010 May; 46(5):637-49. PubMed ID: 19595301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?
    Diwadkar VA; Montrose DM; Dworakowski D; Sweeney JA; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):230-8. PubMed ID: 16318899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resource allocation and fluid intelligence: insights from pupillometry.
    van der Meer E; Beyer R; Horn J; Foth M; Bornemann B; Ries J; Kramer J; Warmuth E; Heekeren HR; Wartenburger I
    Psychophysiology; 2010 Jan; 47(1):158-69. PubMed ID: 19761522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation sensitivity as a moderator of communication disorder in schizophrenia.
    Grant PM; Beck AT
    Psychol Med; 2009 Jul; 39(7):1211-9. PubMed ID: 19379529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain activation mediates the association between structural abnormality and symptom severity in schizophrenia.
    Weinstein S; Woodward TS; Ngan ET
    Neuroimage; 2007 May; 36(1):188-93. PubMed ID: 17398119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pupillary Responses as a Biomarker of Diminished Effort Associated With Defeatist Attitudes and Negative Symptoms in Schizophrenia.
    Granholm E; Ruiz I; Gallegos-Rodriguez Y; Holden J; Link PC
    Biol Psychiatry; 2016 Oct; 80(8):581-8. PubMed ID: 26475673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sympathetic and parasympathetic innervation of pupillary dilation during sustained processing.
    Steinhauer SR; Siegle GJ; Condray R; Pless M
    Int J Psychophysiol; 2004 Mar; 52(1):77-86. PubMed ID: 15003374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intentionality as a link between the neuropsychology and the symptoms of schizophrenia.
    Kaiser S; Weisbrod M
    Psychopathology; 2007; 40(4):221-8. PubMed ID: 17396048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clear distinction between preattentive and attentive process in schizophrenia by visual search performance.
    Tanaka G; Mori S; Inadomi H; Hamada Y; Ohta Y; Ozawa H
    Psychiatry Res; 2007 Jan; 149(1-3):25-31. PubMed ID: 17123633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid visual information processing in schizophrenic patients: the impact of cognitive load and duration of stimulus presentation. A pilot study.
    Cattapan-Ludewig K; Hilti CC; Ludewig S; Vollenweider FX; Feldon J
    Neuropsychobiology; 2005; 52(3):130-4. PubMed ID: 16110246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.